학술논문
Intravenous ( IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
Document Type
Article
Author
Source
Subject
*MULTIPLE myeloma treatment
*INTRAVENOUS therapy
*BORTEZOMIB
*SUBCUTANEOUS infusions
*TREATMENT effectiveness
*
*
*
*
Language
ISSN
0007-1048
Abstract
The article discusses a study conducted to evaluate the sensitivity of patients with multiple myeloma to intravenous (IV) bortezomib after their lack of response to the administration of subcutaneous bortezomib. IV-treated patients were found to have achieved higher rates of good partial response than patients who were treated with subcutaneous bortezomib.